HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Money | Image credit: Stillfx - stock.adobe.com
Freeze in International Funding Could Significantly Reverse Progress in HIV Treatment

April 3rd 2025

Countries located in sub-Saharan Africa would be most affected by all funding cuts to the international HIV response.

HIV Prevention | Image credit: Nadzeya - stock.adobe.com
Elimination of Division of HIV Prevention Could Have Consequences for HIV Response

March 25th 2025

PrEP | Image credit: wladimir1804 - stock.adobe.com
Elimination of HIV Prevention Division Being Considered by Trump Administration

March 20th 2025

Different forms of ART | Image credit: jarun011 - stock.adobe.com
Long-Acting Injectable Cabotegravir Effective in Both ART, PrEP

March 12th 2025

ART | Image credit: Sakdatorn - stock.adobe.com
DTG/3TC, Fostemsavir Effective as ART for Patients With HIV

March 12th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
April 3rd 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

woman with mask
January 11th 2022

People With HIV at Higher Risk of COVID-19 Infection Even After Vaccination, Study Finds

Hayden E. Klein
Researchers found that fully vaccinated people with HIV have a 41% higher risk of COVID-19 breakthrough infection compared with people without HIV.
Silhouette of a pregnant woman
January 5th 2022

Inflammation Increases Risk of Adverse Birth Outcomes in Women Living With, Without HIV

Maggie L. Shaw
This new study from India investigated outcomes as they pertained to preterm birth, low birth weight, and infant growth measures up to 1 year post delivery.
Gut microbiome
January 4th 2022

HIV, ART May Influence Subdominant Gut Bacteria in Children With HIV

Hayden E. Klein
HIV infection and antiretroviral therapy (ART) may influence subdominant gut bacteria in association with immune status in children living with HIV.
Top 5 HIV for 2021
January 2nd 2022

Top 5 Most-Read HIV Content of 2021

Christina Mattina
This year’s most-read articles on HIV explored vaccine hesitancy, medication acceptance, cardiac health, and more.
Amanda Ely, CEO, CHIVA
December 28th 2021

CHIVA CEO Amanda Ely Explains How Fraser Guidelines Can Help Children With HIV

Maggie L. Shaw Hayden E. Klein
The Fraser guidelines can indicate if a child is fully competent to make their own decisions, including consenting to HIV tests if they may be at risk, explained Amanda Ely, CEO of the Children’s HIV Association (CHIVA) of the United Kingdom and Ireland.
Pregnant person holding pills
December 25th 2021

Study Finds Increased Marijuana Use During Pregnancy, Post Partum Among People With HIV

Hayden E. Klein
Marijuana use by people with HIV during pregnancy and post partum increased over time, with the prevalence of general substance use increasing more post partum.
Anna Brewster, services and volunteer manager, The Food Chain
December 21st 2021

The UK's The Food Chain Combines Food Education and HIV Management

Maggie L. Shaw Hayden E. Klein
HIV specialist dieticians at this London-based charity help people with HIV by providing personalized advice on how nutrition can have a positive effect on their overall health and well-being.
What We're Reading
December 21st 2021

What We’re Reading: Free At-Home COVID-19 Tests; Aduhelm Price Cuts; First Injectable HIV Preventive

AJMC Staff
Up to 500 million at-home COVID-19 test kits will be sent to US households for free, by request; Biogen cut the price of its Alzheimer disease drug Aduhelm nearly in half; the FDA approved the world’s first injectable medication to reduce the risk of sexually transmitted HIV.
Jason Myers, PhD
December 20th 2021

Dr Jason Myers on the Stigma Against New Zealanders Living With HIV

Maggie L. Shaw Hayden E. Klein
Jason Myers, PhD, CEO, of the New Zealand AIDS Foundation, explains how they conducted a New Zealand version of the Stigma Index Research to solve the issue of Māori living with HIV experiencing worsened stigma and discrimination.
HIV red ribbon on globe
December 16th 2021

Disproportionate HIV Risk Among Transgender People Continues

Hayden E. Klein
Compared with the general population of individuals over age 15, transmasculine individuals are almost 7 times more likely to have HIV, and transfeminine individuals are 66 times more likely to have HIV.
Trying to reverse time
December 10th 2021

Care Continuum Improvements Needed for Sexual Minority Men Living With HIV

Maggie L. Shaw
The CDC’s latest Morbidity and Mortality Weekly Report details the care and HIV service disparities that persist among sexual minority men.
HIV test
December 7th 2021

Study Finds Slower Viral Suppression Progress in Children, Adolescents Than Adults With HIV

Hayden E. Klein
The proportions of children and adolescents living with HIV who have achieved viral suppression after antiretroviral therapy initiation were consistently lower than those of adults.
Doctor with red ribbon
December 4th 2021

Indicators for Potential Drug-Drug Interactions Identified Among People Living With HIV

Hayden E. Klein
New data show the prevalence of potential drug-drug interactions varies according to the drug use pattern considered, with people living with HIV using multiple illegal drugs being at the highest risk.
What We're Reading
December 1st 2021

What We're Reading: FDA Panel in Favor of Merck COVID-19 Pill; Aspen Pharmacare, J&J Vaccine Agreement; Newest Strategies to Cure HIV

AJMC Staff
An FDA advisory panel voted in favor of emergency authorization for Merck's COVID-19 pill; South African drug maker Aspen Pharmacare announced that it was finalizing the first agreement to control production of the Johnson & Johnson COVID-19 vaccine in Africa; the International AIDS Society launched its latest strategy to find a cure for HIV.
World AIDS Day Logo
December 1st 2021

Contributor: While Many Americans Refuse COVID-19 Vaccination, People Affected by HIV Have Been Waiting for 40 Years

Perry N. Halkitis, PhD, MS, MPH Kristen D. Krause, PhD, MPH
The social, structural, and economic drivers of HIV are not so different from COVID-19. Still, those who have witnessed the ravages of HIV have been in a 40-year holding pattern when it comes to a vaccine, according to experts from the Rutgers School of Public Health.
Will Nutland, DrPH, PrEPster
November 23rd 2021

Dr Will Nutland Explains the History of PrEP in England

Maggie L. Shaw
Will Nutland, DrPH, is cofounder of PrEPster, an honorary assistant professor at the London School of Hygiene and Tropical Medicine, and an activist.
Black man with doctor
November 19th 2021

Multifaceted Interventions Needed to Increase ART Adherence Among Black Men

Maggie L. Shaw
Adherence to antiretroviral treatment (ART) for HIV among Black sexual minority men who have sex with men remains below that of their White counterparts, as does the resulting viral suppression.
Newspapers.
November 16th 2021

What We're Reading: Immune System Shown to Cure HIV; Premature Births Increasing; Handling Mental Health Crises

AJMC Staff
Researchers have found a second reported case of an immune system potentially curing a person of HIV; US premature birth rates are on the rise in minority groups; most Americans say mental health professionals should be first responders to mental health and suicide situations.
White pills
November 10th 2021

VA Maintained HIV Care Delivery During the COVID-19 Pandemic

Hayden E. Klein
Access to antiretroviral treatment was not disrupted, despite decreased in-person services during the pandemic.
Pregnant woman taking medication
November 9th 2021

Live Birth Linked to Greater HIV Care Engagement in Europe

Maggie L. Shaw
This cohort study of women living with HIV, pregnant and not pregnant, investigated outcomes related to engagement in HIV care following a live birth.
How Focusing on the Positive Could Impact Care of Women With HIV
November 5th 2021

How Focusing on the Positive Could Impact Care of Women With HIV

Mary Caffrey
Accomplishments such as gaining a job or completing an educational program was linked with lower depressive symptoms and undetectable viral load, independent of adherence to anti-retroviral therapy.
Helen Bygrave, MD, Médecins Sans Frontières
November 3rd 2021

Dr Helen Bygrave Discusses Ending Cryptococcal Meningitis for Persons Living With HIV

Maggie L. Shaw
Helen Bygrave, MD, chronic diseases advisor for the Médecins Sans Frontières (MSF; Doctors Without Borders) Access Campaign, explains how the campaign is aiming to eliminate the threat of cryptococcal meningitis among persons living with HIV by 2030.
Depressed person
October 30th 2021

Potential Link Found Between Reduced QOL, Higher BMI Among PLWH

Maggie L. Shaw
Because persons living with HIV (PLWH) are now living longer, issues beyond their positive serostatus are having an adverse impact on their quality of life (QOL), such as obesity; recent research findings note these should be a consideration when choosing how to manage HIV.
Amanda Ely, CEO, CHIVA
October 26th 2021

The UK’s CHIVA Supports Children, Families Living With HIV

Maggie L. Shaw
Amanda Ely, CEO, introduces us to The Children's HIV Association (CHIVA) of the United Kingdom and Ireland and details how the experiences of young persons living with HIV differ from those who acquire the virus as adults.
Jason Myers, PhD
October 21st 2021

Dr Jason Myers Addresses Coverage, Expansion of HIV-Related Services in New Zealand

Maggie L. Shaw
Jason Myers, PhD, CEO of the New Zealand AIDS Foundation, delves into how services related to HIV and AIDS in New Zealand—treatment and prevention, and now holistic services—have been spurred to expansion in recent years.
FDA Approves Low-Dose Tablet Biktarvy for Pediatric Patients
October 18th 2021

FDA Approves Low-Dose Tablet Biktarvy for Pediatric Patients

Hayden E. Klein
The low-dose tablet will help pediatric patients weighing between 14 kg and 25 kg who are virologically suppressed or new to antiretroviral therapy.
Image with PrEP, HIV, Protection
October 15th 2021

PrEP Uptake Still Low Among Those Needing It Most

Maggie L. Shaw
New data presented at IDWeek 2021 show lack of pre-exposure prophylaxis (PrEP) uptake among groups at high risk of HIV infection.
Nicoleta Dascalu, founding member and advocacy manager, ARAS
October 12th 2021

How the Pandemic Forced Change in Providing HIV Services in Romania

Maggie L. Shaw
The American Journal of Managed Care® recently spoke with Nicoleta Dascalu, founding member and advocacy manager of Asociaţia Română Anti-SIDA (ARAS; Romanian Association Against AIDS) to learn more about ARAS, which was founded in April of 1992, just 3 years after the fall of communism in the country.
Red AIDS ribbon against newsprint
October 7th 2021

Lack of Awareness Hindering HIV Vertical Transmission, Prevention Efforts

Maggie L. Shaw
Focused educational improvements are needed for women of reproductive age and those who are pregnant regarding vertical transmission of HIV and its prevention.
Perry N. Halkitis, PhD, MS, MPH, Rutgers
October 5th 2021

Dr Perry N. Halkitis on Achieving Equity in HIV/AIDS and COVID-19

Maggie L. Shaw
Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health and director of the Center for Health, Identity, Behavior and Prevention Studies, discusses how the HIV/AIDS crisis and the ongoing COVID-19 pandemic parallel one another and how both are teaching opportunities.
<1
...
789101112131415
...
31>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo